Roche will buy BioMarin without raising extra money

Note: This section contains information in English only.
Source: Bloomberg
Roche Holding AG, a Swiss based health care company, plans to acquire a California-based BioMarin Pharmaceutical Inc., a company, which produces and develops drugs for treating rare diseases and cancer. A possible cost of the deal can reach $15 billion, and Roche will not borrow extra money to pay for BioMarin. On Thursday Roche Holding AG stocks add 0.03% to $65.79 in New York.

Actual Topics

Subscribe to "Fundamental Analysis" feed

订阅
欲了解更多有关杜高斯贝银行差价合约/外汇交易平台,SWFX和其它相关交易详情,
请致电我们或要求回电。
For further information regarding potential cooperation,
please call us or make callback request.
To learn more about Dukascopy Bank Binary Options / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
欲了解更多有关杜高斯贝银行差价合约/外汇交易平台,SWFX和其它相关交易详情,
请致电我们或要求回电。
To learn more about Crypto Trading / CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Business Introducer and other trading related information,
please call us or make callback request.
For further information regarding potential cooperation,
please call us or make callback request.